SKWD Stock Analysis: Skyward Specialty Insurance | NASDAQ
Insurance - Property & Casualty | NASDAQ, USA | Market Cap: 2.246m USD | 12M Return: 5.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 22.3M
EPS Trend: 97.7%
Qual. Beats: 3
Rev. Trend: 99.6%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 3.4 years of data
Average return per month, with how dependable it is below — did the month move the same way every year (high) or randomly (low). Above 60 is a pattern worth trusting; under 40 is noise.
Skyward Specialty Insurance Group, Inc. (SKWD) is a Houston, Texas-based insurance holding company that provides commercial property and casualty insurance to customers across the United States. Its product range spans general liability, excess liability, professional liability, cyber and media liability, commercial auto, group accident and health, property, agriculture, credit, and surety, as well as workers compensation and specialty reinsurance. The company was incorporated in 2006 under the name Houston International Insurance Group, Ltd. and adopted its current name in November 2020.
As a specialty commercial P&C insurer, Skyward focuses on higher-complexity or niche lines of business typically underwritten on a non-admitted or surplus-lines basis in the U.S. market, where insurers earn revenue through net premiums written while also generating investment income on policyholder reserves (commonly referred to as float). The company went public on NASDAQ on January 13, 2023, and operates within the Financials sector.
- Specialty premium growth accelerates across cyber and professional liability
- Net investment income benefits from elevated interest rate environment
- Combined ratio improves as specialty pricing remains firm
| Net Income: 177.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -1.05 > 1.0 |
| NWC/Revenue: -56.92% < 20% (prev 119.4%; Δ -176.3% < -1%) |
| CFO/TA 0.07 > 3% & CFO 427.9m > Net Income 177.7m |
| Net Debt (-1.37b) to EBITDA (251.0m): -5.47 < 3 |
| Current Ratio: 0.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.9m) vs 12m ago 1.19% < -2% |
| Gross Margin: 31.03% > 18% (prev 27.89%; Δ 3.14% > 0.5%) |
| Asset Turnover: 28.07% > 50% (prev 30.13%; Δ -2.06% > 0%) |
| Interest Coverage Ratio: 17.45 > 6 (EBIT TTM 240.9m / Interest Expense TTM 13.8m) |
| A: -0.13 (Total Current Assets 4.40b - Total Current Liabilities 5.25b) / Total Assets 6.55b |
| B: 0.05 (Retained Earnings 316.9m / Total Assets 6.55b) |
| C: 0.05 (EBIT TTM 240.9m / Avg Total Assets 5.29b) |
| D: 0.23 (Book Value of Equity 1.22b / Total Liabilities 5.32b) |
| Altman-Z'' = -0.14 = B |
| DSRI: 1.34 (Receivables 2.17b/1.32b, Revenue 1.48b/1.21b) |
| GMI: 0.90 (GM 27.89% / 31.03%) |
| AQI: 0.63 (AQ_t 0.33 / AQ_t-1 0.52) |
| SGI: 1.22 (Revenue 1.48b / 1.21b) |
| TATA: -0.04 (NI 177.7m - CFO 427.9m) / TA 6.55b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of July 02, 2026, the stock is trading at USD 58.35 with a total of 888,083 shares traded. Over the past week, the price has changed by +9.41%, over one month by +34.61%, over three months by +38.17% and over the past year by +5.40%.
Current recommended Stop Loss: 55.70 (which is 4.5% or 1.4 ATR below the current price).
Skyward Specialty Insurance has received a consensus analysts rating of 3.83. Therefore, it is recommended to buy SKWD.
- StrongBuy: 3
- Buy: 4
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 60.6 | 3.9% |
P/E Trailing = 13.3494
P/E Forward = 10.7296
P/S = 1.4362
P/B = 1.8003
P/EG = 0.7245
Revenue TTM = 1.48b USD
EBIT TTM = 240.9m USD
EBITDA TTM = 251.0m USD
Long Term Debt = 76.6m USD (from longTermDebt, last quarter)
Short Term Debt = 409.4m USD (from shortTermDebt, last quarter)
Debt = 486.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.37b USD (calculated: Debt 486.0m - CCE 1.86b)
Enterprise Value = 873.9m USD (2.25b + Debt 486.0m - CCE 1.86b)
Interest Coverage Ratio = 17.45 (Ebit TTM 240.9m / Interest Expense TTM 13.8m)
EV/FCF = 2.06x (Enterprise Value 873.9m / FCF TTM 424.3m)
FCF Yield = 48.55% (FCF TTM 424.3m / Enterprise Value 873.9m)
FCF Margin = 28.58% (FCF TTM 424.3m / Revenue TTM 1.48b)
Net Margin = 11.97% (Net Income TTM 177.7m / Revenue TTM 1.48b)
Gross Margin = 31.03% ((Revenue TTM 1.48b - Cost of Revenue TTM 1.02b) / Revenue TTM)
Gross Margin QoQ = 32.98% (prev 30.07%)
Tobins Q-Ratio = 0.13 (Enterprise Value 873.9m / Total Assets 6.55b)
Interest Expense / Debt = 2.84% (Interest Expense 13.8m / Debt 486.0m)
Taxrate = 21.74% (49.4m / 227.1m)
NOPAT = 188.5m (EBIT 240.9m * (1 - 21.74%))
Current Ratio = 0.84 (Total Current Assets 4.40b / Total Current Liabilities 5.25b)
Debt / Equity = 0.40 (Debt 486.0m / totalStockholderEquity, last quarter 1.22b)
Debt / EBITDA = -5.47 (Net Debt -1.37b / EBITDA 251.0m)
Debt / FCF = -3.23 (Net Debt -1.37b / FCF TTM 424.3m)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.36% (Net Income 177.7m / Total Assets 6.55b)
RoE = 17.35% (Net Income TTM 177.7m / Total Stockholder Equity 1.02b)
RoCE = 21.89% (EBIT 240.9m / Capital Employed (Equity 1.02b + L.T.Debt 76.6m))
RoIC = 11.52% (NOPAT 188.5m / Invested Capital 1.64b)
WACC = 6.26% (E(2.25b)/V(2.73b) * Re(7.13%) + D(486.0m)/V(2.73b) * Rd(2.84%) * (1-Tc(0.22)))
Discount Rate = 7.13% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 83.55 | Cagr: 2.53%
[DCF] Terminal Value 77.97% ; FCFF base≈375.9m ; Y1≈430.9m ; Y5≈634.2m
[DCF] Fair Price = 269.3 (EV 9.54b - Net Debt -1.37b = Equity 10.9b / Shares 40.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 97.67 | EPS CAGR: 41.18% | SUE: 1.18 | # QB: 3
Revenue Correlation: 99.55 | Revenue CAGR: 26.64% | SUE: -0.63 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.21 | Chg30d=-1.21% | Revisions=-33% | Analysts=12
EPS current Year (2026-12-31): EPS=4.92 | Chg30d=+1.26% | Revisions=+73% | GrowthEPS=+22.9% | GrowthRev=+36.9%
EPS next Year (2027-12-31): EPS=5.51 | Chg30d=+1.01% | Revisions=+38% | GrowthEPS=+12.1% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: +73%